Home
About Us
Company Profile
Company Culture
Video
Certificate
Products & Solutions
Early Screening
Auxiliary Diagnosis
Interventional Therapy
R&D Center
National Research Team
Qankorey Life Science R&D Center
Industry University Research Cooperation
Qualifications and Patents
News
Industry News
Exhibition News
Company News
Contact
Business Cooperation
FAQ
CN
2024-10-10
Qankorey’s Invitation | Waiting To See You At Medica Germany 2024
Germany Exhibition Preview: Qankorey invite all your valued customers to join us at the exhibition stand:3H12-2 from November 11th to 14th.
2024-09-21
31st World Alzheimer's Day | Let's act now to light up memory
Rong Cao, project director of Qankorey company, introduced in detail the public welfare activities of early screening of Alzheimer's disease over 50 years old in Yuhua District since the end of March to make a phased work results report.
2024-09-20
Warmly Welcome | Nobel Prize Nominee Professor Colin Masters visit Qankorey Life Science R&D Center
Colin L Masters said that he would share this visit with his team, plan new directions and jointly explore more cooperation opportunities together.
2024-08-13
Congratulation | Qankorey’s distributor established succesfully collaborations with Hospital Sultan Abdul Aziz Shah
One Step Dementia Risk Test Kit has been approved by the Malaysian Medical Device Administration (MDA) and is expected to be provided to hospitals and clinics nationwide.
2024-08-01
Qankorey’s Invitation | meet in 2024 AAIC Philadelphia, USA
Welcome to visit us at Booth No. 616 to learn about our One Step Dementia Risk Test Kit, which is Urine-based amyloid-β(Aβ) biomarker testing for risk of Alzheimer's Disease.
2024-04-01
Big Event | Qankorey attended Kuala Lumpur Hospital Academic Conference
In the future, Qankorey will actively cooperate with the local market team to inject strong impetus into the cause of Malaysian people's brain health and continue to promote brain health screening for middle-aged and elderly people.
2024-03-28
Good News | Qankorey Launch a public welfare campaign for risk screening in the asymptomatic stage of Alzheimer's disease.
Jun Wang, President of China Association for Alzheimer's Disease(CAAD), made a speech on the significance of AD early screening in China.